Call for tenders: Next Generation Sequencing for Oncology

Increasing the use of Next Generation Sequencing (NGS) in oncology requires further cost reduction and technology acceleration. 8 health procurers from 5 countries (BE, FR, DE, ES, IT) invite potentially interested bidders to submit an offer for their oncNGS pre-commercial procurement.

Aim of the procurement is to develop an affordable integrated solution for predictive, prognostic and diagnostic analysis in liquid biopsies of solid tumours based on NGS technology. Deadline for submission of offers: extended to 17 October 2022.

Tags:

ads
  • Show Comments

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

You May Also Like

I4MS Disruptors Awards: recognising excellence in SMEs and mid-caps

The European initiative ICT for Manufacturing SMEs (I4MS) will award the companies that have ...

Pan-European Hackathon #EUvsVirus to develop innovative solutions

  The European Commission and EU member states have today launched a call for ...

X
/